The latest prospects of investigational drugs for head and neck cancer

Expert Opin Investig Drugs. 2017 Mar;26(3):265-268. doi: 10.1080/13543784.2017.1279145. Epub 2017 Jan 10.

Authors

Olgun Elicin¹, Mahmut Ozsahin²

Affiliations

¹ a Department of Radiation Oncology , Inselspital, Bern University Hospital and University of Bern , Bern , Switzerland.
² b Department of Radiation Oncology , University of Lausanne, Centre Hospitalier Universitaire Vaudois (CHUV) , Lausanne , Switzerland.

PMID: 28056562
DOI: 10.1080/13543784.2017.1279145

No abstract available

Keywords: Chemotherapy; drug development; head and neck cancer; systemic treatment; targeted therapy.

Publication types

Editorial

MeSH terms

Antineoplastic Agents / administration & dosage
Antineoplastic Agents / therapeutic use
Carcinoma, Squamous Cell / drug therapy*
Carcinoma, Squamous Cell / pathology
Carcinoma, Squamous Cell / therapy*
Drug Design
Drugs, Investigational / administration & dosage
Drugs, Investigational / therapeutic use*
Head and Neck Neoplasms / drug therapy*
Head and Neck Neoplasms / pathology
Head and Neck Neoplasms / therapy*
Humans
Squamous Cell Carcinoma of Head and Neck

Substances

Antineoplastic Agents
Drugs, Investigational